US clears new antibiotic for UTIs
The US Food and Drug Administration has approved a new antibacterial drug to treat patients with complicated urinary tract infections (UTI).
Read More
Tag: vaborbactam
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
